Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Medtronic announces CE Mark and European launch of first implantable cardioverter-defibrillator system to allow for full-body MRI scans

Medtronic today announced CE (Conformité Européenne) Mark and European launch of the Evera MRI(tm) SureScan implantable cardioverter-defibrillator (ICD) System, the first and only ICD system approved for magnetic resonance imaging (MRI) scans positioned on any region of the body. The Medtronic Evera MRI ICD is not approved in the United States.

Covidien recalls embolization, retrieval devices

Covidien is recalling some endovascular devices due to a coating defect.

FDA OKs use of biventricular pacing for less severe HF

The FDA expanded the indication for biventricular pacing using two types of cardiac resynchronization therapy devices to treat patients with atrioventricular block and mild to moderate heart failure (HF).

Europeans call for trials akin to caliber of HTN-3

The European Society of Hypertension (ESH) is calling for rigorous trials on renal denervation as a therapy for patients with treatment-resistant hypertension in the wake of results presented in the failed SYMPLICITY HTN-3 clinical trial.

Thumbnail

Circ retracts paper by its editor-in-chief

The journal Circulation retracted a 2012 article in which its editor-in-chief is a senior author, citing compromised data.

Adult Congenital Heart Association names new executive director

The Adult Congenital Heart Association (ACHA), a national nonprofit organization dedicated to improving and extending the lives of adults with congenital heart defects (CHD), announced today the appointment of Glenn R. Tringali as its new National Executive Director.

'IN.PACT Admiral' drug-coated balloon From Medtronic outperforms standard angioplasty In landmark study

Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. than with standard balloon angioplasty, according to a landmark clinical study reported on today for the first time.

EDWARDS INTUITY Elite valve system receives CE mark

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark for the advanced EDWARDS INTUITY Elite valve system. This next-generation, rapid deployment system facilitates smaller incisions in surgical aortic valve replacement (AVR) procedures, and is built upon extensive evidence supporting the durability of the Carpentier-Edwards PERIMOUNT heart valve design.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.